Effectiveness of contact-based education for reducing mental illness-related stigma in pharmacy students

Scott B Patten, Alfred Remillard, Leslie Phillips, Geeta Modgill, Andrew Ch Szeto, Aliya Kassam, David M Gardner, Scott B Patten, Alfred Remillard, Leslie Phillips, Geeta Modgill, Andrew Ch Szeto, Aliya Kassam, David M Gardner

Abstract

Background: A strategy for reducing mental illness-related stigma in health-profession students is to include contact-based sessions in their educational curricula. In such sessions students are able to interact socially with a person that has a mental illness. We sought to evaluate the effectiveness of this strategy in a multi-centre study of pharmacy students.

Methods: The study was a randomized controlled trial conducted at three sites. Because it was necessary that all students receive the contact-based sessions, the students were randomized either to an early or late intervention, with the late intervention group not having participated in the contact-based education at the time when the primary outcome was assessed. The primary outcome, stigma, was assessed using an attitudes scale called the Opening Minds Survey for Health Care Providers (OMS-HC).

Results: We initially confirmed that outcomes were homogeneous across study centres, centre by group interaction, p = 0.76. The results were pooled across the three study centres. A significant reduction in stigma was observed in association with the contact-based sessions (mean change 4.3 versus 1.5, t=2.1, p=0.04). The effect size (Cohen's d) was 0.45. A similar reduction was seen in the control group when they later received the intervention.

Conclusions: Contact-based education is an effective method of reducing stigma during pharmacy education. These results add to a growing literature confirming the effectiveness of contact-based strategies for stigma reduction in health profession trainees.

Figures

Figure 1
Figure 1
Schematic of study procedures*. *CBE = Contact Based Education.

References

    1. Thornicroft G. Shunned: Discrimination against people with mental illness. New York: Oxford University Press; 2006.
    1. Goffman I. Stigma: Notes on the Management of Spoiled Identity. Harmondsworth, Middlesex: Penguin; 1963.
    1. Smith M. Stigma. Advances in Psychiatric Treatement. 2002;8:317–323. doi: 10.1192/apt.8.5.317.
    1. Cipolle RJ, Strand LM, Morley PC. Pharmaceutical care practice: the clinician’s guide. 2. New York: McGraw-Hill; 2004.
    1. Finley PR, Crismon ML, Rush AJ. Evaluating the impact of pharmacists in mental health: a systematic review. Pharmacotherapy. 2003;23:1634–1644. doi: 10.1592/phco.23.15.1634.31952.
    1. Corrigan PW. The impact of stigma on severe mental illness. Cognitive and Behavioral Practice. 1999;5:201–222.
    1. Phokeo V, Sproule B, Raman-Wilms L. Community pharmacists’ attitudes toward and professional interactions with users of psychiatric medication. Psychiatr Serv. 2004;55:1434–1436. doi: 10.1176/appi.ps.55.12.1434.
    1. Murphy PA, Kern SE, Stanczyk FZ, Westhoff CL. Interaction of St. John’s Wort with oral contraceptives: effects on the pharmacokinetics of norethindrone and ethinyl estradiol, ovarian activity and breakthrough bleeding. Contraception. 2005;71:402–408. doi: 10.1016/j.contraception.2004.11.004.
    1. Black E, Murphy AL, Gardner DM. Community pharmacist services for people with mental illnesses: preferences, satisfaction, and stigma. Psychiatr Serv. 2009;60:1123–1127. doi: 10.1176/appi.ps.60.8.1123.
    1. Scheerder G, De CI, Van AC. Pharmacists’ role in depression care: a survey of attitudes, current practices, and barriers. Psychiatr Serv. 2008;59:1155–1160. doi: 10.1176/appi.ps.59.10.1155.
    1. Liekens S, Smits T, Laekeman G, Foulon V. Pharmaceutical care for people with depression: Belgian pharmacists’ attitudes and perceived barriers. Int J Clin Pharm. 2012;34:452–459. doi: 10.1007/s11096-012-9628-0.
    1. Rickles NM, Dube GL, McCarter A, Olshan JS. Relationship between attitudes toward mental illness and provision of pharmacy services. J Am Pharm Assoc. 2010;50:704–713. doi: 10.1331/JAPhA.2010.09042.
    1. Bell JS, Aaltonen SE, Airaksinen MS, Volmer D, Gharat MS, Muceniece R. et al.Determinants of mental health stigma among pharmacy students in Australia, Belgium, Estonia, Finland, India and Latvia. Int J Soc Psychiatry. 2010;56:3–14. doi: 10.1177/0020764008097621.
    1. Bell JS, Johns R, Chen TF. Pharmacy students‘ and graduates’ attitudes towards people with schizophrenia and severe depression. Am J Pharm Educ. 2006;70:77. doi: 10.5688/aj700477.
    1. Jermain DM, Crismon ML. Students’ attitudes toward the mentally ill before and after clinical rotations. Am J Pharm Educ. 1991;55:45–48.
    1. Bell JS, Johns R, Rose G, Chen TF. A comparative study of consumer participation in mental health pharmacy education. Ann Pharmacother. 2006;40:1759–1765. doi: 10.1345/aph.1H163.
    1. Corrigan PW, Larson J, Sells M, Niessen N, Watson AC. Will filmed presentations of education and contact diminish mental illness stigma? Community Ment Health J. 2007;43:171–181. doi: 10.1007/s10597-006-9061-8.
    1. Couture S, Penn DI. Interpersonal contact and the stigma of mental illness: a review of the literature. J Ment Health. 2003;12:291–305. doi: 10.1080/09638231000118276.
    1. Pinfold V, Thornicroft G, Huxley P, Farmer P. Active ingredients in anti-stigma programmes in mental health. Int Rev Psychiatry. 2005;17:123–131. doi: 10.1080/09540260500073638.
    1. Kassam A, Papish A, Modgill G, Patten S. The development and psychometric properties of a new scale to measure mental illness related stigma by health care providers: The Opening Minds Scale for Health Care Providers (OMS-HC) BMC Psychiatry. 2012;12:62. doi: 10.1186/1471-244X-12-62.
    1. Kassam A, Glozier N, Leese M, Henderson C, Thornicroft G. Development and responsiveness of a scale to measure clinicians’ attitudes to people with mental illness (medical student version) Acta Psychiatr Scand. 2010;122:153–161. doi: 10.1111/j.1600-0447.2010.01562.x.
    1. Stata Corporation. Stata, version 11.0. [11.0] College Station, TX: Stata Corporation; 2009.
    1. Pettigrew TF, Tropp LR. How does intergroup contact reduce prejudice? Meta-analytic tests of three mediators. Eur J Soc Psychol. 2008;38:922–934. doi: 10.1002/ejsp.504.
    1. Pettigrew TF, Tropp LR. A meta-analytic test of intergroup contact theory. J Pers Soc Psychol. 2006;90:751–783.
    1. O’Reilly CL, Bell JS, Chen TF. Mental health consumers and caregivers as instructors for health professional students: a qualitative study. Soc Psychiatry Psychiatr Epidemiol. 2012;47:607–613. doi: 10.1007/s00127-011-0364-x.
    1. O’Reilly CL, Bell JS, Chen TF. Consumer-led mental health education for pharmacy students. Am J Pharm Educ. 2010;74:167. doi: 10.5688/aj7409167.
    1. Buhler AV, Karimi RM. Peer-level patient presenters decrease pharmacy students’ social distance from patients with schizophrenia and clinical depression. Am J Pharm Educ. 2008;72:106. doi: 10.5688/aj7205106.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する